Albuterol Dosing for Pediatric Asthma Emergencies
For children presenting with acute asthma exacerbations in the emergency department, administer albuterol 0.15 mg/kg (minimum 2.5 mg) via nebulizer every 20 minutes for 3 doses, or 4-8 puffs via MDI with spacer every 20 minutes for 3 doses, then reassess and continue every 1-4 hours as needed. 1
Initial Dosing Algorithm
For Children ≥2 Years (Including Ages 2-12)
Nebulized Albuterol:
- 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses 1
- After initial 3 doses: 0.15-0.3 mg/kg up to 10 mg every 1-4 hours as needed
- For severe/refractory cases: continuous nebulization at 0.5 mg/kg/hour 1
MDI with Spacer (equally effective for mild-moderate exacerbations):
- 4-8 puffs (90 mcg/puff) every 20 minutes for 3 doses 1
- Then every 1-4 hours as needed
- Use with valved holding chamber and face mask for children <4 years 1
For Infants <2 Years
While the FDA label indicates approval for children ≥2 years 2, recent evidence demonstrates inhaled albuterol can be safely used in children under 2 years with acute wheeze 3. The same weight-based dosing applies (0.15 mg/kg), but MDI with spacer is potentially safer than nebulized formulation in this age group 3.
Severity-Based Approach
Mild-Moderate Exacerbations
- MDI with spacer is as effective as nebulizer and may be preferred 1, 4
- Even 2 puffs via MDI with spacer provides equivalent benefit to higher doses or nebulizer 4
- Results in less tachycardia compared to nebulizer 4
Severe Exacerbations
- Higher doses (0.15 mg/kg) every 20 minutes are superior to lower doses (0.05 mg/kg) 5
- Studies demonstrate significantly greater FEV1 improvement and lower hospitalization rates with 0.15 mg/kg dosing 5
- Add ipratropium bromide 0.25-0.5 mg to albuterol every 20 minutes for 3 doses in severe cases 1
Life-Threatening/Refractory Cases
- Continuous albuterol nebulization at 0.5 mg/kg/hour 1
- Recent evidence suggests starting at 10 mg/hour provides comparable outcomes to 15 mg/hour with shorter treatment duration 6
- Consider IV magnesium sulfate (25-75 mg/kg up to 2g) after 1 hour of intensive treatment 1
Critical Safety Considerations
Cardiovascular Monitoring:
- Expect heart rate increases—this is not a contraindication to continued therapy 7, 5
- Studies show no correlation between serum albuterol levels and cardiac side effects 7, 5
- No severe cardiac effects requiring withdrawal have been reported even with high-dose therapy 3, 5
Common Pitfalls to Avoid:
- Don't underdose in severe exacerbations—0.15 mg/kg is proven superior to 0.05 mg/kg 5
- Don't delay repeat dosing—every 20 minutes for first 3 doses is critical 1
- Don't assume nebulizer is always superior—MDI with spacer is equally effective for mild-moderate cases and has fewer side effects 1, 4
- Don't withhold in infants <2 years—safety data supports use with proper technique 3
Administration Technique
Nebulizer:
- Dilute to minimum 3 mL at gas flow 6-8 L/min 1
- Delivery time: 5-15 minutes 2
- Can mix with ipratropium in same nebulizer 1
MDI with Spacer:
- Requires proper technique and coaching 1
- Use valved holding chamber 1
- Face mask mandatory for children <4 years 1
Adjunctive Therapy
Always add systemic corticosteroids:
- Prednisone/prednisolone 1-2 mg/kg (max 60 mg/day) in 2 divided doses 1
- No advantage to IV over oral if GI absorption intact 1
For severe exacerbations, add ipratropium:
- 0.25-0.5 mg every 20 minutes for 3 doses 1
- Benefit limited to first 3 hours; no additional benefit once hospitalized 1
The evidence strongly supports aggressive early dosing with frequent reassessment rather than conservative approaches that may lead to treatment failure and hospitalization.